@wilfredo_nk Profile picture

Wilfredo F. Garcia-Beltran, MD, PhD

@wilfredo_nk

Puerto Rican 🇵🇷 physician-scientist 🧪👨🏻‍🔬🩺👨🏻‍⚕️ @MGHPathology @ragoninstitute studying human immunology (NK cells!) and immune responses to COVID-19

Similar User
Ragon Institute photo

@ragoninstitute

Ty Miller Lab photo

@TyMillerLab

UHAS photo

@UHASGhana

Tyler Starr photo

@tylernstarr

Adam Nitido photo

@adamnitido

SYNLAB UK & Ireland photo

@SYNLAB_UK

Hernandez Moura Silva photo

@hernandezmsilva

Angelique Hölzemer photo

@AHoelzemer

Upasana DasAdhikari photo

@UpasanaDA

Swetha Anandhan photo

@swetha_anandhan

sumali bajaj photo

@SumaliBajaj

Soo Mi Lee photo

@SooMiLee_

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

The #Evavold lab @ragoninstitute is hiring a new #technician. Please retweet & share the link below. Ideal for recent grads looking for a couple years of research experience prior to MD or PhD. partners.taleo.net/careersection/…

Tweet Image 1

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

The study led by faculty member @wilfredo_nk and BSL3 Core co-director Julie Boucau has provided new insights that could lead to novel treatments. ragoninstitute.org/latest-news/ra… #COVID19 #ScienceNews #Immunology #Cell #Research

Tweet Image 1

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Preprint: SARS-CoV-2 evades NKG2D recognition by ORF6-mediated downregulation of MIC-A/B via shedding, which could be suppressed to enhance NK cell killing of infected cells @wilfredo_nk dx.doi.org/10.2139/ssrn.4…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Why I love my job: PRISM Science Club 2023 of @ragoninstitute and @MIT_IMES is off to a great start! After a a fantastic talk by Ragon Director @brucedwalkermd we learned about transfusion medicine, blood typing, and killer T-cells from physician-scientist @wilfredo_nk

Tweet Image 1
Tweet Image 2
Tweet Image 3

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Our new paper delineates #ROS #control of #GSDMD #pore forming activity. C192 is necessary & sufficient for ROS #enhancement of pores and #pyroptosis. #Ragulator controls one arm of many potential ROS inputs. @CellReports @ragoninstitute @harvardmed cell.com/cell-reports/f…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Let the holidays begin! Spectacular performance by the @ragoninstitute choir at our Winter Holiday Party. Kudos to Choirmaster and NK cell maven Wilfredo Garcia-Beltran and the rest of the harmonious members!

Tweet Image 1

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

During #NationalHispanicHeritageMonth, we spoke with @wilfredo_nk "It’s really important to develop a support system ... You’ll feel so justified and validated and know that yes, you can." ragoninstitute.org/latest-news/fi…

Tweet Image 1

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Our preprint showing that SARS-CoV-2 ORF7a inhibits antigen presentation by disrupting the MHC-I peptide loading complex is out. Led by Fengwen Zhang with help from Trinity Zang and great collaboration with @AwesomeJonesLab @wilfredo_nk, and Julie Boucau biorxiv.org/content/10.110…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

We are hiring at the ⁦@PRScienceTrust1⁩. We are looking for a dynamic and highly motivated person to lead our Sponsored Research Programs Office. Great salary. Awesome place to work! glassdoor.com/partner/jobLis…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

AddThis | Home authors.elsevier.com/a/1exmgL7PXio3… Checkout Aaron Rongqing Pan's new paper just out today online in @CellCellPress . NK cells don't kill by magic, they exploit target cell programmed cell death pathways, and these can be augmented by drugs to make NKs kill better. 1/2


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Vectored ImmunoProphylaxis (VIP) produces broadly neutralizing antibody (VRC07) in humans! I'm incredibly proud to have been able to participate in the development of VIP from the very beginning and am excited to see where this goes next! nature.com/articles/s4159…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

#Host #immune #epigenetic reader #SP140 creates an antibacterial setpoint that sensitizes #mice & #humans to #gut #inflammation. Welcome @fraschillair to twitter for her study led by @KateJeffrey1 @Harvard_Imm @harvardmed @MGH_RI @broadinstitute biorxiv.org/content/10.110…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

ICYMI: watch the recording of the @cambridgepl event "Variants, Breakthroughs, and Boosters: Understanding Omicron and the Future of the COVID-19 Pandemic." @wilfredo_nk and @GaihaGaurav were guest speakers with @CambHealth director @Derricklneal22 youtube.com/watch?v=X_7sjS…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals ✏️ @wilfredo_nk 7, A John Iafrate 4 🗓️ 2022 Feb 3 🌐 pubmed.ncbi.nlm.nih.gov/35202566/ #MGHPathPublication


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Attention Mass undergrads and community college students who went to HS in Boston, Cambridge, Revere, Brockton or other gateway city: check out the RISE summer internships at the @ragoninstitute DM me with questions. ragoninstitute.org/get-involved/i…


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

Paper comparing vaccine effectiveness based on Puerto Rico data finally published: sciencedirect.com/science/articl… Unpopular conclusion, J&J not as effective, and it being an observational study made publishing challenging. Nice to see confirmation from independent lab-based study:

Tweet Image 1

Wilfredo F. Garcia-Beltran, MD, PhD Reposted

In the latest issue! Omicron’s message on vaccines: Boosting begets breadth dlvr.it/SJPxQp


Wilfredo F. Garcia-Beltran, MD, PhD Reposted

In the latest issue! mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant dlvr.it/SJNGqR


Loading...

Something went wrong.


Something went wrong.